A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinibAmir Hossein Daneshmanesh, Håkan Mellstedt, Anders Österborg et al.|PLoS ONE|2018Cited by 43
First-in-Class ROR1 Small Molecule Inhibitor (KAN0439834) Downregulated Wnt-Canonical and Non-Canonical Signaling Pathways and Induced Apoptosis of CLL CellsMohammad Hojjat‐Farsangi, Håkan Mellstedt, Ali Moshfegh et al.|Blood|2015Cited by 6
Diffuse Large B Cell Lymphoma (DLBCL) Expresses ROR1 and a ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Tumor CellsMohammad Hojjat‐Farsangi, Håkan Mellstedt, Amineh Ghaderi et al.|Blood|2019Cited by 6
A new class of anti-cancer drugs targeting the tyrosine kinase receptor ROR1 in CLL.Håkan Mellstedt, Ali Moshfegh, Salam Khan et al.|Journal of Clinical Oncology|2015Cited by 4
First-in-Class Oral Small Molecule Against the Tyrosine Kinase ROR1 (KAN0439834) Induced Significant Apoptosis of Chronic Lymphocytic Leukemia CellsMohammad Hojjat‐Farsangi, Håkan Mellstedt, Amir Hossein Daneshmanesh et al.|Blood|2017Cited by 1